129 related articles for article (PubMed ID: 23765539)
1. Breast cancer in Ghanaian women: what has changed?
Edmund DM; Naaeder SB; Tettey Y; Gyasi RK
Am J Clin Pathol; 2013 Jul; 140(1):97-102. PubMed ID: 23765539
[TBL] [Abstract][Full Text] [Related]
2. Impact of hormone replacement therapy on the histologic subtype of breast cancer.
Zanetti-Dällenbach RA; Krause EM; Lapaire O; Gueth U; Holzgreve W; Wight E
Arch Gynecol Obstet; 2008 Nov; 278(5):443-9. PubMed ID: 18335229
[TBL] [Abstract][Full Text] [Related]
3. Bilateral breast cancer.
Gogas J; Markopoulos C; Skandalakis P; Gogas H
Am Surg; 1993 Nov; 59(11):733-5. PubMed ID: 8239195
[TBL] [Abstract][Full Text] [Related]
4. TNM staging and classification (familial and nonfamilial) of breast cancer in Jordanian females.
Atoum MF; Hourani HM; Shoter A; Al-Raheem SN; Al Muhrib TK
Indian J Cancer; 2010; 47(2):194-8. PubMed ID: 20448386
[TBL] [Abstract][Full Text] [Related]
5. Histopathological features of breast cancer in Al-Madinah region of Saudi Arabia.
Albasri A; Hussainy AS; Sundkji I; Alhujaily A
Saudi Med J; 2014 Dec; 35(12):1489-93. PubMed ID: 25491214
[TBL] [Abstract][Full Text] [Related]
6. Breast cancer as heterogeneous disease: contributing factors and carcinogenesis mechanisms.
Kravchenko J; Akushevich I; Seewaldt VL; Abernethy AP; Lyerly HK
Breast Cancer Res Treat; 2011 Jul; 128(2):483-93. PubMed ID: 21225455
[TBL] [Abstract][Full Text] [Related]
7. Risk of invasive breast carcinoma among women diagnosed with ductal carcinoma in situ and lobular carcinoma in situ, 1988-2001.
Li CI; Malone KE; Saltzman BS; Daling JR
Cancer; 2006 May; 106(10):2104-12. PubMed ID: 16604564
[TBL] [Abstract][Full Text] [Related]
8. Twenty-year incidence and patterns of contralateral breast cancer after breast conservation treatment with radiation.
Hill-Kayser CE; Harris EE; Hwang WT; Solin LJ
Int J Radiat Oncol Biol Phys; 2006 Dec; 66(5):1313-9. PubMed ID: 16997501
[TBL] [Abstract][Full Text] [Related]
9. Changing incidence rate of invasive lobular breast carcinoma among older women.
Li CI; Anderson BO; Porter P; Holt SK; Daling JR; Moe RE
Cancer; 2000 Jun; 88(11):2561-9. PubMed ID: 10861434
[TBL] [Abstract][Full Text] [Related]
10. Gender differences in breast cancer: analysis of 13,000 breast cancers in men from the National Cancer Data Base.
Greif JM; Pezzi CM; Klimberg VS; Bailey L; Zuraek M
Ann Surg Oncol; 2012 Oct; 19(10):3199-204. PubMed ID: 22766989
[TBL] [Abstract][Full Text] [Related]
11. Breast cancer in Iran: an epidemiological review.
Mousavi SM; Montazeri A; Mohagheghi MA; Jarrahi AM; Harirchi I; Najafi M; Ebrahimi M
Breast J; 2007; 13(4):383-91. PubMed ID: 17593043
[TBL] [Abstract][Full Text] [Related]
12. Breastfeeding and prognostic markers in breast cancer.
Lööf-Johanson M; Brudin L; Sundquist M; Thorstenson S; Rudebeck CE
Breast; 2011 Apr; 20(2):170-5. PubMed ID: 20851603
[TBL] [Abstract][Full Text] [Related]
13. The importance of multifocal/multicentric tumor on the disease-free survival of breast cancer patients: single center experience.
Ustaalioglu BO; Bilici A; Kefeli U; Şeker M; Oncel M; Gezen C; Gumus M; Demirelli F
Am J Clin Oncol; 2012 Dec; 35(6):580-6. PubMed ID: 21926901
[TBL] [Abstract][Full Text] [Related]
14. Incidence of invasive breast cancer and ductal carcinoma in situ in a screening program by age: should older women continue screening?
Erbas B; Amos A; Fletcher A; Kavanagh AM; Gertig DM
Cancer Epidemiol Biomarkers Prev; 2004 Oct; 13(10):1569-73. PubMed ID: 15466971
[TBL] [Abstract][Full Text] [Related]
15. Relationship of clinical and pathologic response to neoadjuvant chemotherapy and outcome of locally advanced breast cancer.
Gajdos C; Tartter PI; Estabrook A; Gistrak MA; Jaffer S; Bleiweiss IJ
J Surg Oncol; 2002 May; 80(1):4-11. PubMed ID: 11967899
[TBL] [Abstract][Full Text] [Related]
16. Important increase of invasive lobular breast cancer incidence in Geneva, Switzerland.
Verkooijen HM; Fioretta G; Vlastos G; Morabia A; Schubert H; Sappino AP; Pelte MF; Schäfer P; Kurtz J; Bouchardy C
Int J Cancer; 2003 May; 104(6):778-81. PubMed ID: 12640687
[TBL] [Abstract][Full Text] [Related]
17. Disease Severity, Presentation, and Clinical Outcomes Among Adolescents With Malignant Breast Neoplasms: A 20-Year Population-Based Outcomes Study From the SEER Database (1973-2009).
Murthy V; Pawar S; Chamberlain RS
Clin Breast Cancer; 2017 Aug; 17(5):392-398. PubMed ID: 28602452
[TBL] [Abstract][Full Text] [Related]
18. Contralateral breast cancer: factors associated with stage and size at presentation.
Mertens WC; Hilbert V; Makari-Judson G
Breast J; 2004; 10(4):304-12. PubMed ID: 15239788
[TBL] [Abstract][Full Text] [Related]
19. Does the benefit of sentinel node frozen section vary between patients with invasive duct, invasive lobular, and favorable histologic subtypes of breast cancer?
Chan SW; LaVigne KA; Port ER; Fey JV; Brogi E; Borgen PI; Cody HS
Ann Surg; 2008 Jan; 247(1):143-9. PubMed ID: 18156934
[TBL] [Abstract][Full Text] [Related]
20. Lobular breast cancer: same survival and local control compared with ductal cancer, but should both be treated the same way? analysis of an institutional database over a 10-year period.
Fortunato L; Mascaro A; Poccia I; Andrich R; Amini M; Costarelli L; Cortese G; Farina M; Vitelli C
Ann Surg Oncol; 2012 Apr; 19(4):1107-14. PubMed ID: 21913022
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
